Stock Updates

Teva Pharmaceutical Industries Limited (NYSE: TEVA) – Is this large market cap stock undervalued?

Teva Pharmaceutical Industries Limited (NYSE: TEVA), is firmly in the large market cap category with market cap of 48836.26. To be considered a large market cap stock companies have to be valued at more than $10 billion. The current price for Teva Pharmaceutical Industries Limited is 48.68 (with a change from open of -2.01%), this in conjunction with a target price of 68.36. Volume today has so far reached 9135900, with an average volume of about 5825.1. The GAP for this stock, is 0.42%.

The P/E ratio is 32.5, bringing the forward P/E to a value of 8.2. The current EPS for Teva Pharmaceutical Industries Limited, is 1.5, with a EPS growth for this year coming to a value of -48.90%. Performance has been interesting with performance year to date coming to -24.41%.

Looking further into the growth statistics for Teva Pharmaceutical Industries Limited, EPS is looking like it will grow 12.92% in the next year. Looking even further it is projected to be 5.70%. Quarter over quarter is -67.40% for EPS growth and for sales growth quarter over quarter it is 1.40%. Looking at past EPS growth statistics we see that for the past five years it has been -13.10%. Sales growth for the past five years has in fact been 4.00%.

Looking at the ownership, we see that the insider ownership is at 2.70% and institutional ownership is 59.30%. Shares outstanding is 1003.21, while shares float is at a value of 1003.21. Float short for Teva Pharmaceutical Industries Limited is 0.98% and the short ratio is 1.69.

In terms of debt, long term debt/equity is 0.27, while the total debt/equity comes to 0.36. The ability to meet these debts, means that the current ratio is 1.3, and the quick ratio is 1. The most recent gross margin is 57.70% and their operating margin is 17.70%. The profit margin is 6.90%.

Teva Pharmaceutical Industries Limited has seen returns on assets of 2.50%, and on investment, 5.70%. Return on equity is 4.90%. Price/Earnings to growth ratio is 5.7. Price/Sales ratio is at a value of 2.5, with Price/book ratio coming to 1.48 and Price/cash is 6.99, and finally Price/Free cash Flow is 9.68.

The simple moving averages are -7.02% and -11.33% for 20 day and 200 day simple moving average respectively. For the 52 week high and low the 52 week high is -25.44% and the 52 week low is 2.05%.

Teva Pharmaceutical Industries Limited has a dividend yield of 2.79%, with a current price of 48.68. The ability to pay this means the payout ratio is 67.50%. This is in an industry, Drug Manufacturers – Other, with equally high dividends from other companies in this sector, which it is Healthcare. Teva Pharmaceutical Industries Limited is based in Israel.

Performance in the Drug Manufacturers – Other industry means that Teva Pharmaceutical Industries Limited has seen performance for the past week of -3.57%, with performance for the month coming to -4.08%. Looking at the data for the quarter it is at a value of -2.52%, and for the half year the performance is -9.39%. Volatility for this week is 2.09% and for the month this is 1.78%.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Stephen Butters

Leave a Comment